Zacks Investment Research
30 Jul 2026, 23:00 UTC · 3d ago
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
30 Jul 2026, 23:00 UTC · 3d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Merit Medical reported an EPS of $1.19, beating the Zacks Consensus Estimate of $0.96 by 23.96%. — A significant earnings beat typically drives immediate positive price action and upward revisions in analyst models.
+0.60Merit Medical's quarterly revenue grew 9.5% year-over-year to $418.84 million, exceeding the $404.67 million consensus estimate. — Top-line growth and a revenue beat confirm organic demand and operational scaling, supporting a bullish outlook.
+0.40Merit Medical's EPS increased from $1.01 in the prior year's period to $1.19 in the current quarter. — Consistent year-over-year earnings growth demonstrates improving profitability and fundamental health.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company reported revenue and EPS that both beat analyst expectations and showed year-over-year growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Fox Business
2h ago
